Feedback / Questions
CAP-003 - Capsida Biotherap
https://www.businesswire.com/news/home/20250611109903/en/Capsida-Receives-FDA-IND-Clearance-for-Its-IV-Administered-Gene-Therapy-for-Parkinsons-Disease-Associated-With-GBA-Mutations
Jun 11, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next